PODXL and cancer: In terms of ethnicity, the results demonstrated that high PODXL expression was an unfavorable prognostic factor in cancers in European (HR=1.67, 95%CI=1.40-1.99, p<0.00001; I2=48%, p=0.05), in North American (HR=1.92, 95%CI=1.48-2.49, p<0.00001) and in Asian (HR=1.51, 95%CI=1.12-5.62, p=0.03).